Cargando…
Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
Autores principales: | Pan, Yinghong, Robertson, Gordon, Pedersen, Lykke, Lim, Emilia, Hernandez-Herrera, Anadulce, Rowat, Amy C., Patil, Sagar L., Chan, Clara K., Wen, Yunfei, Zhang, Xinna, Basu-Roy, Upal, Mansukhani, Alka, Chu, Andy, Sipahimalani, Payal, Bowlby, Reanne, Brooks, Denise, Thiessen, Nina, Coarfa, Cristian, Ma, Yussanne, Moore, Richard A., Schein, Jacquie E., Mungall, Andrew J., Liu, Jinsong, Pecot, Chad V., Sood, Anil K., Jones, Steven J.M., Marra, Marco A., Gunaratne, Preethi H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370050/ https://www.ncbi.nlm.nih.gov/pubmed/28403581 http://dx.doi.org/10.18632/oncotarget.15921 |
Ejemplares similares
-
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
por: Pan, Yinghong, et al.
Publicado: (2016) -
MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
por: Patil, Sagar L., et al.
Publicado: (2019) -
PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity
por: Basu-Roy, Upal, et al.
Publicado: (2016) -
Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients
por: Liu, Kelly Yi Ping, et al.
Publicado: (2020) -
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors
por: Gunaratne, Preethi H., et al.
Publicado: (2019)